Ian Kerridge

Biography

 Ian Kerridge is an internationally recognized scholar in bioethics and the philosophy of medicine. From 2003 to 2015 he was Director of the Centre for Values, Ethics and the Law in Medicine (VELiM) at the University of Sydney. He is currently Professor of Bioethics and Medicine at VELiM and Haematologist/Bone Marrow Transplant Physician at Royal North Shore Hospital, Sydney. He is also the Chair of the Australian Bone Marrow Donor Registry (ABMDR) Ethics Committee, board member of the Australasian Association of Bioethics and Health Law (AABHL) and a member of the NSW Clinical Ethics Advisory Group. Since 2003, Professor Kerridge has secured over $28 million in competitive research grants ($10 million in the last 5 years) and has been a Chief Investigator on 15 NHMRC grants, 2 Cure Cancer NSW grants, 3 ARC Linkage grants and 4 NHMRC Centres of Research Excellence grants. He has published 10 textbooks/monographs of bioethics/philosophy (most recently, Ethics and Law for the Health Professions, Fourth Edition (Federation Press; 2013)), 27 book chapters on ethics, research ethics and infectious diseases and over 270 papers in peer-reviewed journals on ethics, medical philosophy and haematology. He is a reviewer for more than 20 academic journals and is an editorial board member of the Journal of Bioethical Inquiry and the Asian Bioethics Review. In 2005 he was the expert ethicist on the Legislative Review Committee appointed by the Commonwealth to review the operation of the Prohibition of Human Cloning Act 2002 and the Research Involving Human Embryos Act 2002. (A Bill based upon the recommendations of the Committee was passed by both Houses of Parliament in November, 2006).

Research Interest

 Professor Kerridge's research focuses on the philosophical, moral and socio-cultural concepts, frameworks and issues that underpin health, health policy and biomedicine including in public health, research and clinical care. His research in ethics explores such topics as public health ethics, stem cells, end-of-life care, the experience of illness and survival, over-diagnosis, synthetic genomics, infectious diseases, organ transplantation, cord blood and tissue banking and donation, research ethics, publication, drug policy and the pharmaceutical industry. His research in haematology is focussed on the late effects of bone marrow transplantation, survivorship and myeloma.